INCREASED SHOCK IMPEDANCE IS ASSOCIATED WITH FAILED SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR DEFIBRILLATION THRESHOLD TESTING

Implantable cardioverter defibrillator with and without defibrillation threshold testing.

BACKGROUND Defibrillation threshold (DFT) testing at the time of implantable cardioverter defibrillator (ICD) insertion is performed routinely. This practice is being reconsidered due to doubts about its ability to improve ICD efficacy and evidence that survival may not be affected by the test. OBJECTIVES To compare the outcome of ICD recipients who underwent DFT testing and those who did not...

Subcutaneous implantable cardioverter-defibrillator.

or nearly 3 decades, the implantable cardioverter-defibrillator (ICD) has been available to patients who survived life-threatening rapid heart rhythms or are at risk of experiencing them. The ICD comprises a device generator coupled with a defibrillation lead. Traditional ICDs are implanted under the skin with the generator positioned beneath the collar bone. The defibrilla-tion lead is inserte...

Subcutaneous implantable cardioverter defibrillator.

Is defibrillation testing necessary for implantable transvenous defibrillators?: defibrillation testing is necessary at the time of implantable cardioverter defibrillator implantation.

Effects of shock polarity reversal on defibrillation threshold in an implantable cardioverter-defibrillator.

BACKGROUND An increased defibrillation threshold (DFT) may limit the efficacy of an implantable cardioverter-defibrillator (ICD) in termination of life-threatening ventricular arrhythmias. A search for methods of decreasing DFT has been ongoing since the introduction of ICD into clinical practice. AIM To assess the effects of various shock polarities on DFT. METHODS The study group consiste...